Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZD (PF-05231023) 是一种属于 PEG 类的 PROTAC linker,可用于 PROTAC 的合成分子。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 328 | 现货 | ||
2 mg | ¥ 493 | 现货 | ||
5 mg | ¥ 897 | 现货 | ||
10 mg | ¥ 1,390 | 现货 | ||
25 mg | ¥ 2,810 | 现货 | ||
50 mg | ¥ 3,660 | 现货 | ||
100 mg | ¥ 5,270 | 现货 | ||
200 mg | ¥ 7,430 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,160 | 现货 |
产品描述 | Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZD (PF-05231023) is a long-acting fibroblast growth factor 21 (FGF21) analog and is an FGF21-receptor agonist. It is also suitable for development as a potential treatment for T2DM. |
体外活性 | PF-05231023 is a analog of long-acting fibroblast growth factor 21 [2]. |
体内活性 | PF-05231023 suppresses oxidative-stress-induced inflammation in photoreceptors. PF-05231023 decreases the variability of retinal NRF2 levels and displays a trend (non-significant) towards increased NRF2 levels in Akita mice. PF-05231023 decreases retinal IL-1β mRNA expression in Akita mice. PF-05231023 enhances cone-specific arrestin4 expression in Akita mice. PF-05231023 restores photoreceptor morphology in Akita mice. Administration of native FGF21 and PF-05231023 (3?mg/kg or 10?mg/kg; subcutaneously twice a week for two weeks) improves glucose tolerance and liver insulin sensitivity in Zucker rats. PF-05231023 (10 mg/kg; intraperitoneally injected) reduces retinal inflammation in diabetic mice [3][4]. |
别名 | PF-05231023 |
分子量 | 528.55 |
分子式 | C26H32N4O8 |
CAS No. | 1037589-69-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 125 mg/mL (236.50 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.892 mL | 9.4598 mL | 18.9197 mL | 47.2992 mL |
5 mM | 0.3784 mL | 1.892 mL | 3.7839 mL | 9.4598 mL | |
10 mM | 0.1892 mL | 0.946 mL | 1.892 mL | 4.7299 mL | |
20 mM | 0.0946 mL | 0.473 mL | 0.946 mL | 2.365 mL | |
50 mM | 0.0378 mL | 0.1892 mL | 0.3784 mL | 0.946 mL | |
100 mM | 0.0189 mL | 0.0946 mL | 0.1892 mL | 0.473 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZD 1037589-69-7 Angiogenesis PROTAC Tyrosine Kinase/Adaptors FGFR PROTAC Linker PF-05231023 Mal-amido-PEG-2-C2-amido-Ph-C2-CO-AZD PROTAC Linkers MalamidoPEG2C2amidoPhC2COAZD Inhibitor Mal amido PEG2 C2 amido Ph C2 CO AZD inhibit PF05231023 PF 05231023 inhibitor